Avedro, Inc.

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Strategic Transactions. Aevi Obtains Option For AstraZ

Company Changes ADENT , John To: Neogen Corp. , CEO (July) From: Animal Health International, CEO Phone: 517-372-9200 ARENA , Paul To: Parallax Health Sciences Inc. , CEO (July) From: Arena

Company Changes AGARWAL , Sunil, MD To: Juno Therapeutics Inc. , Pres., R&D (April) From: Ultragenyx Pharmaceutical Inc., EVP, CMO Phone: 206-582-1600 AL-WAKEEL Yasir To: Neon Therapeutics

[ Editors' note : For more details about VC deals in 2017 and previous years, go to Medtech Insight's VC deal tracker: https://medtech.pharmamedtechbi.com/datasets/vc-funding ] Deal volume bounce